Skip to main content

Multikinase inhibitors

What are Multikinase inhibitors?

Multikinase inhibitors work by inhibiting multiple intracellular and cell surface kinases, some of which are implicated in tumor growth and metastatic progression of cancer, thus decreasing tumor growth and replication. Multikinase inhibitors may be used to treat advanced kidney cancer as well as other specific types of cancer.

List of Multikinase inhibitors

View by  Brand | Generic
Drug Name Avg. Rating Reviews
ruxolitinib systemic (Pro)
7.3
 40 reviews
sunitinib systemic (Pro)
7.2
 35 reviews
cabozantinib systemic (Pro)
6.0
 22 reviews
nintedanib systemic (Pro)
7.5
 19 reviews
sorafenib systemic (Pro)
5.6
 15 reviews
regorafenib systemic (Pro)
4.5
 14 reviews
deucravacitinib systemic (Pro)
5.1
 7 reviews
crizotinib systemic (Pro)
7.8
 7 reviews
selpercatinib systemic (Pro)
10
 5 reviews
midostaurin systemic (Pro)
7.4
 5 reviews
vemurafenib systemic (Pro)
6.2
 4 reviews
lenvatinib systemic (Pro)
5.3
 4 reviews
trametinib systemic (Pro)
7.3
 3 reviews
avapritinib systemic (Pro)
3.7
 3 reviews
afatinib systemic (Pro)
7.7
 3 reviews
ponatinib systemic (Pro)
3.0
 2 reviews
dabrafenib systemic (Pro)
7.5
 2 reviews
axitinib systemic (Pro)
9.0
 2 reviews
alectinib systemic (Pro)
9.5
 2 reviews
selumetinib systemic (Pro)
9.0
 1 review
ripretinib systemic (Pro)
1.0
 1 review
pemigatinib systemic (Pro)
1.0
 1 review
momelotinib systemic (Pro)
8.0
 1 review
larotrectinib systemic (Pro)
1 review
gilteritinib systemic (Pro)
8.0
 1 review
fedratinib systemic (Pro)
1.0
 1 review
erdafitinib systemic (Pro)
10
 1 review
encorafenib systemic (Pro)
1.0
 1 review
ceritinib systemic (Pro)
5.0
 1 review
vandetanib systemic (Pro)
No reviews
umbralisib systemic
No reviews
tepotinib systemic (Pro)
No reviews
ritlecitinib systemic (Pro)
No reviews
repotrectinib systemic (Pro)
No reviews
quizartinib systemic (Pro)
No reviews
pralsetinib systemic (Pro)
No reviews
pexidartinib systemic (Pro)
No reviews
pacritinib systemic (Pro)
No reviews
lorlatinib systemic (Pro)
No reviews
infigratinib systemic (Pro)
No reviews
futibatinib systemic
No reviews
fruquintinib systemic (Pro)
No reviews
entrectinib systemic (Pro)
No reviews
cobimetinib systemic (Pro)
No reviews
capmatinib systemic (Pro)
No reviews
capivasertib systemic (Pro)
No reviews
brigatinib systemic (Pro)
No reviews
binimetinib systemic (Pro)
No reviews
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

See also

Medical conditions treated or associated with multikinase inhibitors:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer